Kymera Therapeutics, Inc. (KYMR)
108.33
+3.55
(+3.39%)
USD |
NASDAQ |
Oct 19, 12:25
Kymera Therapeutics Total Liabilities (Quarterly) : 136.19M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 136.19M |
| March 31, 2026 | 129.38M |
| December 31, 2025 | 163.15M |
| September 30, 2025 | 155.79M |
| June 30, 2025 | 159.59M |
| March 31, 2025 | 132.08M |
| December 31, 2024 | 142.42M |
| September 30, 2024 | 141.91M |
| June 30, 2024 | 141.10M |
| March 31, 2024 | 157.05M |
| December 31, 2023 | 180.79M |
| September 30, 2023 | 156.84M |
| June 30, 2023 | 146.52M |
| March 31, 2023 | 151.90M |
| Date | Value |
|---|---|
| December 31, 2022 | 112.98M |
| September 30, 2022 | 125.59M |
| June 30, 2022 | 125.47M |
| March 31, 2022 | 134.34M |
| December 31, 2021 | 146.27M |
| September 30, 2021 | 159.32M |
| June 30, 2021 | 176.28M |
| March 31, 2021 | 189.30M |
| December 31, 2020 | 203.29M |
| September 30, 2020 | 212.68M |
| June 30, 2020 | 77.07M |
| March 31, 2020 | |
| December 31, 2019 | 82.03M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 129.46M |
| Twist Bioscience Corp. | 226.70M |
| Beam Therapeutics, Inc. | 318.91M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.645B |
| Shareholders Equity (Quarterly) | 1.509B |
| Debt to Equity Ratio | 0.0521 |
| Current Ratio | 10.34 |
| Net Debt Paydown Yield | 0.02% |